Operating Expenses

R&D

Veeva Systems R&D increased by 3.6% to $198.79M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $181.53M to $198.79M. Over 4 years (FY 2022 to FY 2026), R&D shows an upward trend with a 19.0% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

20 periods
 Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$83.23M$94.90M$98.64M$105.28M$113.48M$134.01M$130.26M$142.54M$146.96M$157.23M$161.28M$163.57M$162.71M$176.43M$172.41M$181.53M$184.03M$192.68M$191.88M$198.79M
QoQ Change+14.0%+3.9%+6.7%+7.8%+18.1%-2.8%+9.4%+3.1%+7.0%+2.6%+1.4%-0.5%+8.4%-2.3%+5.3%+1.4%+4.7%-0.4%+3.6%
YoY Change+36.3%+41.2%+32.1%+35.4%+29.5%+17.3%+23.8%+14.8%+10.7%+12.2%+6.9%+11.0%+13.1%+9.2%+11.3%+9.5%
Range$83.23M$198.79M
CAGR+20.1%
Avg YoY Growth+19.6%
Median YoY Growth+13.9%

Business Segments

View all
SegmentQ2 '25Q3 '25Q4 '25Q1 '26
Reportable Segment$136.08M$139.29M$139.09M$148.03M
Total$184.03M$192.68M$191.88M$198.79M

Frequently Asked Questions

What is Veeva Systems's r&d?
Veeva Systems (VEEV) reported r&d of $198.79M in Q4 2025.
How has Veeva Systems's r&d changed year-over-year?
Veeva Systems's r&d increased by 9.5% year-over-year, from $181.53M to $198.79M.
What is the long-term trend for Veeva Systems's r&d?
Over 4 years (2022 to 2026), Veeva Systems's r&d has grown at a 19.0% compound annual growth rate (CAGR), from $382.04M to $767.39M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.